Royal Bank of Canada reissued their outperform rating on shares of Spire Healthcare Group (LON:SPI) in a research report sent to investors on Tuesday, ThisIsMoney.Co.Uk reports.
Several other equities analysts also recently weighed in on the stock. Peel Hunt raised shares of Spire Healthcare Group to a buy rating in a report on Thursday, March 19th. Jefferies Financial Group downgraded shares of Spire Healthcare Group to an underperform rating and boosted their target price for the stock from GBX 106 ($1.39) to GBX 113 ($1.49) in a report on Tuesday, January 21st. Peel Hunt reissued an add rating and issued a GBX 155 ($2.04) target price on shares of Spire Healthcare Group in a report on Wednesday, January 8th. Liberum Capital reissued a hold rating on shares of Spire Healthcare Group in a report on Wednesday, March 18th. Finally, Barclays reaffirmed an underweight rating on shares of Spire Healthcare Group in a research note on Tuesday, January 7th. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the stock. The stock currently has an average rating of Hold and an average target price of GBX 130.88 ($1.72).
Shares of LON SPI opened at GBX 79.10 ($1.04) on Tuesday. The firm has a 50 day moving average of GBX 106.26 and a 200 day moving average of GBX 120.15. The company has a current ratio of 1.03, a quick ratio of 0.77 and a debt-to-equity ratio of 124.33. The firm has a market capitalization of $299.01 million and a price-to-earnings ratio of 43.94. Spire Healthcare Group has a 12-month low of GBX 61.25 ($0.81) and a 12-month high of GBX 145 ($1.91).
The firm also recently declared a dividend, which will be paid on Tuesday, June 23rd. Investors of record on Thursday, May 28th will be paid a dividend of GBX 2.50 ($0.03) per share. This is an increase from Spire Healthcare Group’s previous dividend of $1.30. The ex-dividend date of this dividend is Thursday, May 28th. This represents a yield of 2.26%. Spire Healthcare Group’s dividend payout ratio is presently 2.22%.
Spire Healthcare Group Company Profile
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Recommended Story: Coverage Ratio
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.